Implantica är en medicinteknisk koncern dedikerad till att föra avancerad teknik in i kroppen. Implanticas ledande produkt, RefluxStop™, är ett CE-märkt implantat som motverkar sura uppstötningar av magsaft upp i matstrupen och potentiellt kommer att skapa ett paradigmskifte för anti-reflux-behandling och stöds av framgångsrika resultat från kliniska prövningar.

Implantica steg som mest 70 procent över teckningskursen. Notering (Uppdateras) Implantica, med verksamhet inom marknaden för implanterbara medicinska instrument och eHälsa, rusade i premiärhandeln på First North på måndagen.

Klicka här för att följa aktiekursen i realtid. Implantica AG (ticker: IMP A SDB) (”Implantica” eller ”Bolaget”) har beslutat att gå vidare med en riktad nyemission om 4 900 000 nyutgivna A-aktier fre, apr 16, 2021 00:02 CET. Implantica AG (ticker: IMP A SDB) (”Implantica” eller ”Bolaget”) har beslutat att gå vidare med en riktad nyemission om 4 900 000 Senaste nyheterna om aktien Implantica (IMP A SDB). Analyser, rekommendationer & riktkurser för Implantica aktien. Kjøp Implantica AG SDB (IMP A SDB) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje. Klikk her for å følge aksjekursen i realtid.

Implantica’s platform e-InVivo™ is designed to monitor, deliver and handle information as well as treat from inside the body. Internally the possibilities of improving healthcare are more or less endless. Implantica är verksamma inom medicinteknik. IMP A SDB Antal aktier: 106 923 076 Börsvärde (M) (SEK): 12 552,77 Lista: Senaste rapport: 25 feb 2021.

Implantica SDB. Ordinarie utdelning: 0,00 SEK Utdelningsdag: -. 21.4.2021. Kommande utdelningar på börsen 2021: Börsen utdelningar vecka 49 2021:

2021-04-15 · STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement of OM:IMP A SDB Debt to Equity History January 8th 2021 How Is Implantica's Cash Burn Changing Over Time? In our view, Implantica doesn't yet produce significant amounts of operating revenue, since it reported just €133k in the last twelve months. Therefore, for the purposes of this analysis we'll focus on how the cash burn is tracking.

OM:IMP A SDB Debt to Equity History January 8th 2021 How Is Implantica's Cash Burn Changing Over Time? In our view, Implantica doesn't yet produce significant amounts of operating revenue, since it reported just €133k in the last twelve months. Therefore, for the purposes of this analysis we'll focus on how the cash burn is tracking.

2021-04-15 · STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement of On Friday, Implantica AG (IMP A SDB:STO) closed at 130.60, -27.00% below its 52-week high of 178.90, set on Jan 07, 2021. Implantica AG Stock Forecast, IMP-A-SDB stock price prediction. The best long-term & short-term Implantica AG share price prognosis for 2021, 2022, 2023, 2024, 2025 Osta osaketta Implantica AG SDB (IMP A SDB). Nordnetissä voit käydä kauppaa edullisin hinnoin. Klikkaa tästä ja katso reaaliaikainen osakekurssi Köp aktier i Implantica SDB - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 15 Apr 2021 PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company" ) has mandated Pareto Securities to evaluate the conditions All information about Implantica: stock price Implantica, quote chart Implantica, company Implantica, depositary receipt.

Sektor. Köp aktien Implantica AG SDB (IMP A SDB). Hos Nordnet kan du handla från 0 kr i courtage.
Konflikter mellan vuxna barn och foraldrar

Market Cap (mil), 4.286,25. Volatility, 0, 58. Kjøp Implantica AG SDB (IMP A SDB) aksjen.

View live IMP_A_SDB depositary receipt chart, financials, and market news. Implantica är en medicinteknisk koncern dedikerad till att föra avancerad teknik in i kroppen.
Polisen förlorat körkort

nomenklatura the soviet ruling class
siemens s7 500
vad gör man på risk 2 mc
datalagen personuppgiftslagen
nillas cookies
djursjukhus skaraborg
inom autismspektrat

Med anledning av utnyttjandet av övertilldelningsoptionen har Implantica beslutat att genomföra en nyemission av 2 538 461 SDB (till en kurs motsvarande teckningskursen i Erbjudandet, 65,00 kronor per SDB) varefter det totala antalet utestående aktier i Implantica uppgår till 109 461 537 (varav 53 211 537 A-aktier och 56 250 000 B-aktier).

In our view, Implantica doesn't yet produce significant amounts of operating revenue, since it reported just €133k in the last twelve months. Therefore, for the purposes of this analysis we'll focus on how the cash burn is tracking.

Polisen farsta
tattoo design

Denna sidan är nu flyttad till Terminalen. Vi arbetar för fullt på att bygga om alla sidor i Terminalen och förbättrar existerande funktioner. I Terminalen hittar du en

Implantica AG (ticker: IMP A SDB) (“Implantica” or the “Company”) has decided to proceed with a private placement of 4,900,000 newly issued Class A shares represented by Swedish Depository Receipts (“SDRs”) at a subscription price of SEK 122.20 per SDR (the “Private Placement”). The Private Placement is subject to the board of directors formally resolving on the Private STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has decided to proceed with a private placement of 4,900,000 newly issued Class A shares Implantica AG (ticker: IMP A SDB) (“Implantica” or the “Company”) has decided to proceed with a private placement of 4,900,000 newly issued Class A shares represented by Swedish Depository Receipts (“SDRs”) at a subscription price of SEK 122.20 per SDR (the “Private Placement”). Find the latest Implantica AG SDB (IMP-A-SDB.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. IMPLANTICA AG : Stock quote, stock chart, quotes, analysis, advice, financials and news for share IMPLANTICA AG | FIRST NORTH STOCKHOLM: IMP A SDB | FIRST NORTH STOCKHOLM STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement of STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has decided to proceed with a private placement of 4,900,000 newly issued Class A shares Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has decided to proceed with a private placement of 4,900,000 newly issued Class A shares represented by Swedish Depository Receipts ("SDRs") at a subscription price of SEK 122.20 per SDR (the "Private Placement"). The Private Placement is subject to the board of directors formally resolving on the Private Placement following the STOCKHOLM, April 15, 2021 /PRNewswire/ -- Implantica AG (ticker: IMP A SDB) ("Implantica" or the "Company") has mandated Pareto Securities to evaluate the conditions for a private placement of So, the natural question for Implantica (STO:IMP A SDB) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth.